Kamada Ltd KMDA 深 滬
等待開盤 06-25 09:30:00 美东时间
7.135
+0.005
+0.07%
華盛通- 最 高7.19
- 今 開7.17
- 成交量 1.73万股
- 最 低 7.115
- 昨 收 7.13
- 總市值 4.12亿
- 52周最高 9.10
- 市盈率 靜 20.61
- 換手率 0.03%
- 52周最低 6.25
- 委 比 88.03%
- 總股本 5769.43万
- 歷史最高 17.50
- 量 比 0.34
- 振 幅 1.05%
- 歷史最低 2.57
- 每 手 1
- 風險率 0.73%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Kamada Announces FDA Approval Of New In-House Rapid Fluorescent Focus Inhibition Test Laboratory
Kamada Ltd. (NASDAQ:KMDA, TASE: KMDA.TA))), a global biopharmaceutical company with a portfolio of marketed products indicated for rare and serious conditions and a leader in the specialty plasma-derived therapies field,
06-01 19:05
Kamada Announces FDA Approval of its New In-House Rabies Virus Neutralization Testing Laboratory
Kamada Ltd. announced FDA approval of its new in-house RFFIT laboratory, a gold standard test for rabies-neutralizing antibodies. Located in Israel, the lab enhances the company's capabilities for KEDRAB® and KAMRAB® manufacturing. The lab, also approved by Health Canada and the Israeli Ministry of Health, supports operational efficiency and innovation. Kamada's 2025 sales of these products exceeded $70 million, highlighting their importance in t...
06-01 11:00
Kamada shares are trading lower after the company reported worse-than-expected Q1 financial results.
Kamada shares are trading lower after the company reported worse-than-expected ...
05-13 23:47
Kamada Q1 2026 Earnings Call: Complete Transcript
On Wednesday, Kamada (NASDAQ:KMDA) discussed first-quarter financial results du...
05-13 20:59
Earnings Scheduled For May 13, 2026
Companies Reporting Before The Bell • Similarweb (NYSE:SMWB) is estimated to re...
05-13 19:11
Kamada Affirms FY2026 Sales Guidance of $200.000M-$205.000M vs $201.581M Est
Kamada (NASDAQ:KMDA) affirms FY2026 sales outlook from $200.000 million-$205.000 million to $200.000 million-$205.000 million vs $201.581 million estimate.
05-13 19:02
Kamada Q1 EPS $0.07 Misses $0.12 Estimate, Sales $45.240M Miss $46.722M Estimate
Kamada (NASDAQ:KMDA) reported quarterly earnings of $0.07 per share which missed the analyst consensus estimate of $0.12 by 41.67 percent. This is unchanged from the same period last year. The company reported quarterly
05-13 19:02
全球超免疫球蛋白市场预计2033年突破40亿美元，SCIG疗法与高端国产化驱动行业升级
（来源：百谏方略） 超免疫球蛋白产品介绍 超免疫球蛋白（Hyperimmune Globulins）是专门的血液制品，含有高水平的针对特定病原体的抗体。这些抗体...
04-08 14:31
Kamada Ltd Earnings Call Signals Confident Growth Path
Kamada Ltd (($IL:KMDA)) has held its Q4 earnings call. Read on for the main hig...
04-03 08:21
Kamada Updates on Withholding Tax Procedures on Previously Announced Cash Dividend to Shareholders
Kamada Ltd. has received a tax ruling from the Israel Tax Authority regarding a cash dividend of $0.25 per share, totaling approximately $14.4 million, to be paid on April 7, 2026. Shareholders residing in countries with a tax treaty with Israel may qualify for a reduced withholding tax rate. Documentation requirements and applications must be submitted by May 9, 2026. The company has appointed IBI Trust Management as the tax agent to process the...
03-31 11:00
